Skip to main content
    S

    Sunshine Biopharma Inc (SBFM)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $2.60
    -0.10 (-3.70%)

    Market Cap: $2.22M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Sunshine Biopharma Inc (SBFM) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Sunshine Biopharma (SBFM) is expected to report earnings on Apr 1, 2027. In the quarter ended Sep 30, 2026, Sunshine Biopharma reported EPS of -$5.20, below the -$3.40 estimate. It beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    33%(4/12)
    Avg Surprise
    -114.04%

    Upcoming Estimates

    Reports Apr 1, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$5.92
    RangeN/A
    3 analysts
    Revenue Consensus
    $10.00M
    Range$9.60M - $10.29M
    3 analysts
    Reports May 11, 2027 (est.)Period ending Mar 31, 2027
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A
    0 analysts

    Next Report

    SBFM has an expected report date of Apr 1, 2027.

    Earnings History

    Of the 12 quarters below that had an estimate, SBFM beat 4 and missed 8. Revenue for the quarter ended Sep 30, 2026 was $9.44M, up 0.2% from $9.42M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$5.20-$3.40-$3.40 - -$3.40-52.94%MissN/A11 up, 0 downNov 12, 2026$9.44M
    Jun 30, 2026-$1.15-$1.20-$1.20 - -$1.20+4.17%BeatN/A10 up, 1 downAug 13, 2026$9.26M
    Mar 31, 2026-$2.50-$1.60-$1.60 - -$1.60-56.25%MissN/A10 up, 0 downApr 3, 2026$8.09M
    Dec 31, 2025-$0.46-$0.12N/A-283.33%MissN/A10 up, 1 downFeb 25, 2026$8.58M
    Sep 30, 2025-$1.90-$1.30-$1.30 - -$1.30-46.15%MissN/A10 up, 1 downNov 13, 2025$9.42M
    Jun 30, 2025-$3.90-$1.10N/A-254.55%MissN/AN/A0 up, 0 downAug 12, 2025$9.41M
    Mar 31, 2025-$0.44$0.07N/A-728.57%MissN/AN/A0 up, 0 downMay 15, 2025$8.90M
    Sep 30, 2024-$9.40-$5,350.00N/A+99.82%BeatN/AN/A0 up, 0 downNov 5, 2024$8.44M
    Jun 30, 2024-$1,988.00-$6.00N/AN/AN/AN/A10 up, 0 downAug 18, 2024$9.30M
    Mar 31, 2024-$400.00-$208.00N/A-92.31%MissN/A11 up, 0 downMay 20, 2024$7.54M
    Dec 31, 2023-$5.00-$3.00-$3.00 - -$3.00-66.67%MissN/A10 up, 0 downMar 28, 2024$7.68M
    Sep 30, 2023-$800.00-$1,200.00-$1,200.00 - -$1,200.00+33.33%BeatN/A10 up, 0 downNov 13, 2023$5.96M
    Jun 30, 2023-$400.00-$1,600.00N/A+75.00%BeatN/AN/AN/AAug 10, 2023$5.56M
    Mar 31, 2023-$1.05N/AN/AN/AN/AN/AN/AN/AApr 4, 2023$4.89M
    Dec 31, 2022-$416,411.90N/AN/AN/AN/A-160158524.2%N/AN/ADec 31, 2022$3.94M
    Sep 30, 2022-$0.08N/AN/AN/AN/AN/AN/AN/ANov 7, 2022$132808
    Jun 30, 2022-$0.03N/AN/AN/AN/AN/AN/AN/AAug 3, 2022$150307
    Mar 31, 2022-$0.23N/AN/AN/AN/AN/AN/AN/AMay 6, 2022$122645
    Dec 31, 2021$0.26N/AN/AN/AN/AN/AN/AN/AMar 21, 2022$85118
    Sep 30, 2021-$0.01N/AN/AN/AN/AN/AN/AN/ANov 9, 2021$50376
    Jun 30, 2021-$0.01N/AN/AN/AN/AN/AN/AN/AAug 9, 2021$52874
    Mar 31, 2021-$0.01N/AN/AN/AN/AN/AN/AN/AMay 11, 2021$40058
    Dec 31, 2020-$0.01N/AN/AN/AN/AN/AN/AN/AMar 30, 2021$28013
    Sep 30, 2020$0.00N/AN/AN/AN/AN/AN/AN/ANov 10, 2020$17150
    Jun 30, 2020-$0.01N/AN/AN/AN/AN/AN/AN/AAug 19, 2020$15145
    Mar 31, 2020-$0.01N/AN/AN/AN/AN/AN/AN/AApr 30, 2020$11102
    Dec 31, 2019$0.00N/AN/AN/AN/AN/AN/AN/AMar 31, 2020$10556
    Sep 30, 2019-$0.01N/AN/AN/AN/AN/AN/AN/ANov 13, 2019$7326
    Jun 30, 2019-$0.04N/AN/AN/AN/AN/AN/AN/AAug 15, 2019$3033
    Mar 31, 2019-$0.03N/AN/AN/AN/AN/AN/AN/AApr 12, 2019$206
    Dec 31, 2018-$0.05N/AN/AN/AN/AN/AN/AN/AMar 31, 2019N/A
    Sep 30, 2018-$0.07N/AN/AN/AN/AN/AN/AN/ANov 16, 2018N/A
    Jun 30, 2018-$0.37N/AN/AN/AN/AN/AN/AN/AAug 17, 2018N/A
    Mar 31, 2018-$0.26N/AN/AN/AN/AN/AN/AN/AApr 2, 2018$91168
    Dec 31, 2017-$0.11N/AN/AN/AN/AN/AN/AN/AMar 31, 2018N/A
    Sep 30, 2017-$0.09N/AN/AN/AN/AN/AN/AN/ANov 15, 2017N/A
    Jun 30, 2017-$0.07N/AN/AN/AN/AN/AN/AN/AAug 11, 2017N/A
    Mar 31, 2017-$0.23N/AN/AN/AN/AN/AN/AN/AApr 17, 2017N/A
    Dec 31, 2016-$0.10N/AN/AN/AN/AN/AN/AN/AMar 31, 2017N/A
    Sep 30, 2016-$1.18N/AN/AN/AN/AN/AN/AN/ANov 14, 2016N/A
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$6.70, after -$2,397.40 the year before. It was -$3.10 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$6.70N/A
    Dec 31, 2024-$2,397.40N/A
    Dec 31, 2023-$1,206.05N/A
    Dec 31, 2022-$416,412.24-181048901.3%
    Dec 31, 2021$0.23N/A
    Dec 31, 2020-$0.04N/A
    Dec 31, 2019-$0.08N/A
    Dec 31, 2018-$0.74N/A
    Dec 31, 2017-$0.50N/A
    Dec 31, 2016-$3.10N/A

    Frequently Asked Questions About SBFM

    When is Sunshine Biopharma's next earnings date?

    Sunshine Biopharma's next earnings report is expected for Apr 1, 2027.

    Did SBFM beat earnings estimates last quarter?

    No. Sunshine Biopharma reported EPS of -$5.20 for the quarter ended Sep 30, 2026, below the -$3.40 estimate by 52.94%.

    What EPS do analysts expect from SBFM next quarter?

    The consensus EPS estimate for Sunshine Biopharma for the quarter ending Dec 31, 2026 is -$5.92 from 3 analysts.

    How often does SBFM beat earnings estimates?

    Sunshine Biopharma beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate, with an average surprise of -164.73%.